2018
DOI: 10.1097/md.0000000000010366
|View full text |Cite
|
Sign up to set email alerts
|

Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention

Abstract: Supplemental Digital Content is available in the text

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
5
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 36 publications
(41 reference statements)
0
5
0
Order By: Relevance
“…To the best of our knowledge, this association in OSA patients has not been studied previously. The correlation between LOX-1 and uric acid was described in healthy men [33] and in patients with coronary artery disease [34]. In vitro study show, that xanthine oxidase, which catalyzes the oxidation of xanthine to uric acid, stimulates LOX-1 expression on macrophages and vascular smooth muscle cells and induces foam cell formation through LOX-1 [35].…”
Section: Discussionmentioning
confidence: 99%
“…To the best of our knowledge, this association in OSA patients has not been studied previously. The correlation between LOX-1 and uric acid was described in healthy men [33] and in patients with coronary artery disease [34]. In vitro study show, that xanthine oxidase, which catalyzes the oxidation of xanthine to uric acid, stimulates LOX-1 expression on macrophages and vascular smooth muscle cells and induces foam cell formation through LOX-1 [35].…”
Section: Discussionmentioning
confidence: 99%
“…Since the introduction of percutaneous transluminal coronary angioplasty (PTCA) in 1977, restenosis, which has an occurrence rate of 32%–40% at 6 months after PTCA, has hampered the long‐term efficacy of PTCA. 2 , 17 Use of drug‐eluting stents (DES), which are coated with antiproliferative drugs, such as sirolimus or paclitaxel, has dramatically reduced the occurrence rate of ISR. 18 However, despite the use of dual antiplatelet and intensive statins therapy, the incidence of ISR after PCI remains high.…”
Section: Discussionmentioning
confidence: 99%
“…CAG examination is the “criterion standard” for the judgment of coronary restenosis after PCI, but CAG is an invasive examination and the compliance of patients is low. [ 26 , 27 ] Cardiovascular clinical attention is focused on finding serum markers that can effectively and easily reflect coronary restenosis after PCI. Therefore, some researchers have suggested that the detection of serum inflammatory markers may be more effective in predicting coronary restenosis after PCI.…”
Section: Discussionmentioning
confidence: 99%